“…Our analysis, using luciferase reporter constructs transfected to colorectal cancer cells, supports that TAF4b, but not TAF4, acts as a coactivator on specific AP-1 targets. Furthermore, in our study, we observed that an intracellular reduction of TAF4b might be compensated by induced expression levels of TAF4 (Supplementary Data), reinforcing the previous assumption that TAF4 was limiting the TAF4b-containing TFIID complexes present in cells (36). Interestingly, TAF4 and TAF4b, through their competitive equilibrium in TFIID, have been shown to regulate the expression of genes involved in cell proliferation and transforming growth factor-β signaling, known to drive tumor cells to EMT transformation (41,42).…”